Breaking
June 5, 2026

Health

MGM Healthcare Malar Performs Live Mono-Segment Liver Transplant on 2-Year-Old Child with Primary Hyperoxaluria, Ending Dialysis

Chennai, January 29, 2026: MGM Healthcare Malar, Adyar has successfully performed a complex liver transplant on a two-year-old boy weighing just nine kilograms after his liver failed to produce essential enzymes to clear harmful metabolic waste substances known as oxalates, produced excessively due to a rare genetic disorder, leading to kidney stones and subsequent kidney failure. Following the surgery, the child’s kidney function has improved; while he is no longer dependent on dialysis, a kidney transplant will be required at a later stage.

The young boy was admitted to MGM Healthcare Malar, Adyar with symptoms such as severe vomiting and poor physical growth. He was diagnosed with advanced kidney failure and required peritoneal dialysis, a type of dialysis that uses the lining of the abdomen. Further investigations traced the condition to primary oxaluria, a rare genetic disorder that caused excessive production of oxalates in the body. A deficiency of key liver enzymes prevented the clearance of these oxalates, allowing them to accumulate and form kidney stones.

The boy required a kidney transplant; however, without first correcting the liver’s condition, a new kidney would not function properly and the underlying disease would persist, making a liver transplant a crucial prerequisite for treating his renal condition. The procedure was made possible by the boy’s grandmother, who served as the living donor. Live Donor Mono-Segment Liver transplant was performed and uneventful, and the child’s recovery has been smooth and rapid.
This eliminated the need for dialysis after the transplant, and he is scheduled to undergo a kidney transplant in the coming months.

The surgery was performed by a multi-visceral transplant team led by Dr Anil Vaidya MD, Chair and Director, Institute of Multi-Visceral and Abdominal Organ Transplant, MGM Malar, with support from Dr Senthil Muthuraman, Senior Consultant and Dr Venkatesh BS, Consultant, Multi Visceral Transplant. Anaesthesia was managed by Dr Dinesh Babu Senior Consultant, Anaesthesiology, and late.Dr Nivash Chandrasekaran, Senior Consultant, Dr Saravanan – Senior Consultant.Pre- and post-surgical kidney care was overseen by the nephrology team headed by Dr Srinivasa Prasad ND,Senior Consultant while the hospital’s intensive care unit played a critical role in ensuring the child’s smooth post-operative recovery.

In his comments, Dr Anil Vaidya MD said, “Performing a liver transplant on such a young and underweight child is undeniably complex. Typically, we would wait for a child to gain more weight, but given the severity of his condition, we needed to act promptly. By addressing the liver first, we ensured that the kidneys would function properly afterward. This sequential approach will allow the boy’s body to gradually clear the excess oxalates. Now, within weeks, he’s no longer dependent on dialysis and is thriving. He requires immunosuppressants to ensure the transplant’s success, and we look forward to the upcoming kidney transplant at the right time.”

In his comments, Mr. Venugopal Bhat, COO, MGM Healthcare Malar, said, “We are immensely proud to have achieved this rare and complex milestone. This case shows that renal issues from severe genetic conditions such as primary oxaluria can be successfully treated even at a very young age. The surgery was uneventful thanks to meticulous pre-operative preparation, including thorough assessment of the child’s vascular status and infection profile. Instead of performing the liver and kidney transplants together, as is done at many centres, we adopted a carefully planned sequential approach in the child’s best interest. Following the liver transplant, the child was closely monitored in our ICU for a week, with support from nephrology and other specialist teams. The success of this procedure reflects the seamless coordination and dedication of our multidisciplinary teams.”

MGM Group of Hospitals Conducts BLS Training to Raise Cardiac Emergency Awareness

Chennai, 24 January 2026: In a landmark public health and community preparedness initiative, MGM Healthcare rolled out a city wide Basic Life Support (BLS) training programme across 77 locations on Republic Day 2026 and subsequently felicitated the trainers who played a pivotal role in delivering one of the largest coordinated community life-saving initiatives, empowering citizens with critical first-response skills and reinforcing a culture of emergency preparedness across communities.

India is witnessing an alarming rise in sudden cardiac arrests, including among younger adults. Recent data indicate that over 25% of heart attacks occur in individuals under 40, while 15–20% of sudden cardiac arrest cases affect those below 50, signalling a serious and growing public health concern. With bystander CPR rates remaining critically low, MGM Healthcare’s initiative focused on bridging the critical gap between the onset of a cardiac emergency and timely medical intervention.

“One Nation. One Skill. Infinite Lives.”, the flagship CSR initiative, successfully trained 770+ citizens in a single day across Chennai, Madurai, Visakhapatnam and select outstation districts, making it one of the largest coordinated Basic Life Support (BLS) training efforts conducted in the city and beyond. The programme covered CPR, choking response and AED awareness, with hands-on demonstrations delivered by certified clinicians and trainers from MGM Healthcare.

The training sessions were conducted across public spaces, educational institutions, corporate parks and communities in Chennai and select outstation districts. Participants received the certificate of completion at the end of training session.

As part of the initiative, MGM Healthcare also undertook an attempt to enter the Limca Book of Records for conducting BLS training sessions across the maximum number of locations in a single day.

Speaking on the initiative, Dr Senathi Nanda Kishore, Clinical Director, Senior Consultant & Clinical Lead, Anaesthesiology and Surgical ICU, MGM Healthcare, said, “Every minute matters in a medical emergency. Through this Republic Day initiative, we aimed to ensure that citizens across communities gain the confidence and skills needed to act decisively and save lives before medical help arrives.”

Commenting on the occasion, Mr. Nilesh Mundada, COO and Senior Vice President – Finance, MGM Healthcare, added, “Through sustained Basic Life Support training, MGM Healthcare is committed to building a culture of preparedness and resilience where every citizen is empowered to act as a first responder. Saving a life is not just a medical skill, but a shared civic responsibility, and by training communities at scale, we are strengthening India’s emergency preparedness beyond hospital walls.”

This initiative has reinforced its commitment by extending care beyond hospital walls and fostering sustained public health awareness through continued community engagement.

Kauvery Hospital, Alwarpet Performs One of the World’s First complex TAVR-in-TAVR-in-SAVR Procedure

Kauvery Hospital, Alwarpet Performs One of the World’s First complex TAVR-in-TAVR-in-SAVR Procedure with Bioprosthetic Valve Fracture and Dual Cerebral Protection for a man aged 78 years

Chennai, 22 January 2026: Kauvery Hospital, Alwarpet has successfully performed a highly complex and rare TAVR-in-TAVR-in-SAVR procedure with bioprosthetic valve fracture on a 78-year-old patient, marking one of the first such procedures in the world. The advanced transcatheter intervention was undertaken to treat a repeatedly failing heart valve in a patient with a long and challenging history of aortic valve disease.

The patient was first diagnosed with severe aortic stenosis, a condition where the heart’s main valve narrows and restricts blood flow to the body. In 2005, he underwent open-heart surgery (Surgical Aortic Valve Replacement-SAVR) to replace the diseased valve with a bioprosthetic (tissue) valve. Over time, this valve degenerated, and in 2019, he underwent a transcatheter (TAVR) valve-in-valve replacement—a minimally invasive procedure in which a new valve is placed inside the old surgical valve without reopening the chest.

In the years following the second procedure, the patient once again developed symptoms such as breathlessness and fatigue. Investigations revealed increasing pressure gradients across the valve, indicating that blood flow through the heart valve was again being obstructed. Further evaluation suggested leaflet thrombosis (blood clot in the leaflets) and become thickened, and do not open fully. While anticoagulation medication temporarily improved valve function, the problem recurred whenever treatment was stopped, causing early degeneration of the Transcatheter Heart Valve.

Given the patient’s advanced age, multiple prior valve interventions, and high surgical risk, repeat open-heart surgery was considered a higher risk option.

Upon referral to Kauvery Hospital, Alwarpet, a multidisciplinary heart team led by Dr Rajaram Anantharaman & Dr C Sundar conducted a detailed assessment using advanced 3D echocardiography and CT imaging. These investigations confirmed persistent leaflet thickening and restricted valve opening despite medical therapy, due to under-expandion of the previous placed TAVR allowing leaflets to open in restricted fashion (pin-wheeling). After careful planning, the team decided to proceed with a TAVR-in-TAVR-in-SAVR procedure, placing a new transcatheter valve inside the previously implanted transcatheter valve inside surgical valve.

To further optimise valve expansion and blood flow, a bioprosthetic valve fracture technique was employed. This involves controlled expansion of the existing TAVR in SAVR to high pressure to fracture the frame of the first surgical valve. This will create more space and full expansion of the newly implanted valve, and function more effectively. Given the high neurological (stroke risk) associated with such complex procedures, dual cerebral protection was used during the intervention with two Spider FX devices placed in both Carotids arteries (supplying brain) to reduce the risk of stroke by capturing the debris and preventing from reaching the brain.

The procedure was particularly challenging due to the patient’s bicuspid aortic valve anatomy (two leaflets rather than three) associated aortopathy with moderately dilated aorta (the main artery from the heart was slightly enlarged, increasing procedural risk), and pseudo-coarctation (a narrowing of part of the thoracic aorta with narrowing and tortousity)mimics coarctation, combined with the failure of both a prior surgical valve and a prior transcatheter valve.

Speaking about the case, Dr. Rajaram Ananthraman, Director for Transcatheter Heart Valve Therapies, Kauvery Hospital, Chennai, said,

“The challenging procedure needed meticulous planning and precision by the Heart Valve Team. Despite these complexities, the procedure was successfully completed. The patient showed rapid recovery, was shifted to the ward the next day, and discharged within 48 hours. Post-procedure assessments confirmed excellent valve function, stable neurological status, absence of major complications, and full mobility.”

Commenting on the achievement, Dr. Aravindan Selvaraj, Co-Founder and Executive Director, Kauvery Group of Hospitals, said,

“This case reflects the depth of clinical expertise available at Kauvery Hospital, Alwarpet. Managing such high-risk and complex structural heart cases locally reduces the need for patients to seek care abroad and reinforces Chennai’s growing role as a centre for advanced cardiac interventions.”

Kauvery Hospital, Chennai continues to strengthen its leadership in structural heart disease management through advanced transcatheter procedures, state-of-the-art imaging, and comprehensive multidisciplinary cardiac care, offering patients access to world-class treatment close to home.

India’s Most Comprehensive Heart and Lung Transplant Program Gives Critically Ill Patients a Second Chance at Life

Chennai, 22 January 2026: Apollo Hospitals, Chennai continues to set national benchmarks in the treatment of advanced heart and lung disease, driven by one of India’s most comprehensive heart, lung, and ECMO-supported transplant programs. The transplant team, with significant national and international experience, have performed 600+ heart and lung transplants, managed over 2,000 transplant patients, 1,000+ Extracorporeal Membrane Oxygenation (ECMO) cases, along with 250+ Left Ventricular Assist Devices (LVAD) procedures and 250+ Chronic Thromboembolic Pulmonary Hypertension (CTEPH) interventions.

The multidisciplinary heart-lung transplant and MCS program at Apollo expertly manages patients with end-stage heart and or lung failure, offering personalised solutions for those who no longer respond to maximal medical therapy. Be it a stabilising, bridging or definitive treatment with transplanting hearts and lungs, or implanting durable mechanical cardiac pumps for failing hearts, our patients are supported through a continuum of focused and evidence-based care.

The team also offers comprehensive solutions for even the most complex cardiopulmonary conditions, such as the gold standard treatment of Pulmonary Endarterectomy (PEA) for appropriate patients with CTEPH, where the chronic blood clots in the lung arteries are removed surgically.

The press conference held to mark this milestone featured patients from different age groups and levels of illness severity, who shared how their lives were transformed by the program. Among them were Mr. Raja Sivagurunathan (59), who survived a critical phase on ECMO support for 48 days before undergoing an emergency double-lung transplant; Mr. B. Saravanan (45), who developed sudden and severe lung failure and was supported on life-saving machines for two weeks until a successful lung transplant; and Mr. Radhae Shyam Raghuvanshi (72), whose condition worsened abruptly and who was airlifted to Chennai before receiving a double-lung transplant after advanced support.

Commenting about ECMO and Transplantation, Dr. Srinivas Rajagopala, Senior Consultant & Clinical Lead – Pulmonology, Sleep Medicine and Lung Transplant, Apollo Hospitals Chennai said, “These outcomes demonstrate how early and appropriate use of ECMO can fundamentally alter the course of severe lung failure. It provides a vital bridge allowing time for stabilisation, informed decision-making, and preparation for lung transplantation. Success lies in constant vigilance, multidisciplinary teamwork, and highly personalized care. Our goal is always meaningful recovery, not merely short-term survival.”

Dr. Kumud Kumar Dhital, Head of Heart and Lung Transplantation at Apollo Hospitals, Chennai, emphasized “Patients suffering from advancing heart and lung failure, with escalating medical therapy and declining quality of life, deserve to be informed of the transplant options at a far earlier stage. Outcomes improve significantly when patients are referred early and managed with strong, protocol-driven hospital care. Age itself is not a limitation – what matters is careful evaluation, optimization, meticulous surgery, expert after-care in the ICU, and life-long post-discharge continuity of care so as to maximize chances of long-term survivorship.”

Dr. IIankumaran Kaliamoorthy, CEO – Chennai Region, Apollo Hospitals also participated in the press conference.

As India’s burden of advanced heart and lung disease continues to rise, Apollo Hospitals remains at the forefront of comprehensive cardiothoracic transplantation, combining innovation, expertise, and compassionate care- proving that even the most critical organ failure can be transformed into a second chance at life.

Apollo Hospitals delivers 360-degree care through an integrated, multidisciplinary model involving cardiology, pulmonology, cardiothoracic surgery, anaesthesia, critical care, transplant coordination, rehabilitation, and seamlessly coordinates this with post-discharge and long-term follow-up. The program’s focus extends beyond survival to restoring functional independence and quality of life for patients while fully informing and supporting their families.

ECMO serves as a vital life-support technology within this ecosystem. This mechanical support temporarily takes over the function of the heart and/or lungs when conventional therapies fail. By oxygenating blood outside the body, ECMO allows failing organs to rest and recover or acts as a crucial bridge to recovery or transplantation. The program integrates VV-ECMO for lung support, VA-ECMO for cardiac and combined heart-lung failure. LVADs in the form of implantable and mechanical heart pumps are offered to suitable candidates as durable alternatives or bridge to heart transplantation.

SIMS Hospital Unveils India’s First 24×7 Digital Medical Bus for Rural Communities

Chennai, January , 2026: SIMS Hospital has unveiled SIMS Hello Doctor Health on Wheels, India’s first medical bus designed to deliver essential and comprehensive medical services and teleconsultations with specialists to rural communities. Health on Wheels offers on-the-go consultations, health screenings, vaccinations, and basic diagnostic services backed by a 24×7 medical team.

Thiru. Ma. Subramanian, Hon’ble Minister for Health & Medical Education, Government of Tamil Nadu, flagged off the medical bus in the presence of Tmt. Tamilachi Thangapandiyan, Member of Parliament, South Chennai Constituency, Thiru. A.M.V. Prabhakara Raja, Member of Legislative Assembly, Virugambakkam Constituency, and Dr. Ravi Pachamuthu, Chairman, SRM Group.

The mobile unit enables seamless and paperless end-to-end patient care, including registration, consultation, diagnostics, referrals, and follow-ups, ensuring that individuals receive quality medical attention without the burden of travel or long waiting times. The medical bus provides a wide spectrum of services such as real-time mobile teleconsultations with specialists and super-specialists, vaccination-on-wheels to improve immunisation access and coverage, and one-stop preventive health check-ups for early risk identification.

With a strong focus on preventive healthcare and wellness, SIMS Hello Doctor also facilitates early assessment and detection of non-communicable diseases, particularly in rural and underserved communities.

As part of its operations, the SIMS Hello Doctor medical bus will conduct exclusive health screenings and check-ups across industries, schools, colleges, and rural communities. The medical bus also delivers smart health education and awareness sessions aimed at promoting healthy lifestyles, early intervention, and informed healthcare decisions. An AI-powered chatbot further enhances patient engagement by offering guided assistance, appointment support, and access to verified health information. Under its Mission SIMS VILLAGE framework, the hospital will identify villages through the medical bus to ensure continuous access to preventive, diagnostic, and consultative healthcare services, while strengthening grassroots healthcare delivery on a call to 044 2001 2001.

Speaking on the occasion, Thiru. Ma. Subramanian, Hon’ble Minister for Health & Medical Education, Government of Tamil Nadu, said, “Initiatives such as Hello Doctor Health on Wheels play an important role in strengthening the public healthcare ecosystem by ensuring that medical services reach people where they live. This step signifies the future of healthcare—one that is inclusive, preventive, and accessible. I appreciate SIMS Hospital for taking this forward towards community well-being.”

Commenting on the launch, Tmt. Tamilachi Thangapandiyan said, “Tamil Nadu has gained a global recognition as a preferred destination for medical tourism, offering advanced treatments, skilled doctors. Growing number of foreign patients are choosing Tamil Nadu for affordable and high-quality medical care, strengthening state’s position as a leading healthcare hub in India. I also commend Mr. Ravi Pachamuthu and the SIMS Hospital team for their consistent efforts in delivering quality healthcare services to rural communities, ensuring equitable access to medical care for all.”

Dr. Ravi Pachamuthu, Chairman, SRM Group, said, “At SIMS Hospital, our vision has always been to go beyond hospital walls and reach patients where they need us the most. SIMS Hello Doctor – Health on Wheels reflects our commitment to preventive healthcare, early intervention, and technology-driven care. This 24×7 mobile healthcare service will not only improve health outcomes but also empower communities with awareness and timely medical guidance.” This initiative marks a significant step in redefining healthcare delivery through innovation, outreach, and community-centric care, paving the way for a future where timely and quality medical support is always within reach.

MGM Cancer Institute Saves 41-Year-Old Man with Advanced, Inoperable Tongue Cancer

Chennai, January 6, 2026: Doctors at MGM Cancer Institute have successfully treated a 41-year-old male smoker with advanced tongue cancer (squamous cell carcinoma), a condition previously considered inoperable at several hospitals as the tumour, measuring approximately 5 × 3 cm with significant vertical extension, had spread across the entire anterior tongue, the floor of the mouth, and reached the hyoid bone, a bone in the upper neck that supports the tongue.

The patient underwent a composite resection, a single, extensive surgery aimed at removing all cancer-affected tissue. This included complete removal of the front portion of the tongue (anterior total glossectomy), removal of cancer-involved tissue from the floor of the mouth, and removal of the affected portion of the jaw bone (segmental mandibulectomy). The procedure also required removal of the hyoid bone.

Following complete tumour removal, doctors rebuilt the tongue and mouth using free flap reconstruction, an advanced technique in which healthy tissue from another part of the body was used to restore normal shape and function. As a final step, radiation therapy was administered to eliminate any remaining cancer cells at the microscopic level, ensuring complete cancer control.

The complex medical and surgical procedures were carried out by a multidisciplinary team comprising Dr. M.A. Raja, Director and Senior consultant – Medical Oncology; Dr. Sivaram Ganesamoni, HOD and Senior Consultant, Surgical Oncology; Dr. Manikandan Venkatasubramaniyan, Senior Consultant, Surgical Oncology; Dr. A. Siva Kumar, Plastic Surgeon.

Commenting on the case, Dr. Raja said, “The patient, a known smoker, presented with a persistent ulcer and abnormal growth on the tongue. Clinical examination revealed extensive involvement of the anterior tongue and floor of the mouth. A biopsy confirmed squamous cell carcinoma, a common form of oral cancer. Further evaluation with a whole-body PET scan showed that the tumour had extended deep into the tissues, reaching the hyoid bone.”

He added that considering the advanced stage of the disease and the patient’s young age, the multidisciplinary tumour board recommended chemotherapy given before surgery (neoadjuvant chemotherapy) to shrink the tumour and improve surgical outcomes. “After two cycles of chemotherapy, follow-up PET scans showed a good partial response, following which the patient was reassessed and taken up for surgery,” he said.

In his comments Dr. Sivaram Ganesamoni said, “This case highlights the integration of multimodality expertise in action, delivering results even in a seemingly impossible clinical scenario. Each one of the specialists involved are to be commended for the clinical excellence.”

Explaining the surgical procedure, Dr. Manikandan Venkatasubramaniyan said, “The surgery involved an anterior total glossectomy, which is the complete removal of the front portion of the tongue, along with resection of the entire floor of the mouth. In addition, a segmental mandibulectomy was performed to remove the affected part of the jaw bone on the right side, and the hyoid bone was also removed. To restore the large surgical defect and preserve function, the team carried out advanced reconstruction using a Free Anterolateral Thigh (ALT) flap, in which healthy tissue from the patient’s left thigh was transplanted to rebuild the removed structures. The patient is disease free and is back to his routine life.”

RYA Cosmo Foundation to Host Fundraising Musical Evening Featuring Anuv Jain in Chennai

Chennai, 4th January 2026: RYA Cosmo Foundation, a Chennai-based charitable trust committed to accessible healthcare and early disease detection under its MEDI BANK Project – “Care the Uncared” for the past three decades, is organizing a special fundraising musical evening featuring renowned singer-songwriter Anuv Jain held today at YMCA Grounds, Royapettah, Chennai, in association with Hivefy Events.
The concert aims to support and strengthen the Foundation’s flagship healthcare initiatives — Shanti Devi Jawaharmal Day Care and Diagnostic Centre and Manoharraj Kamala Kankaria Cancer Detection Centre, both of which have been serving the community with affordable, reliable, and quality medical services.
The Shanti Devi Jawaharmal Day Care and Diagnostic Centre provides comprehensive diagnostic and day-care medical facilities with a strong focus on early diagnosis, preventive healthcare, and affordable investigations, catering to people from all walks of life. The Manoharraj Kamala Kankaria Cancer Detection Centre is dedicated to early cancer screening and detection, playing a crucial role in identifying cancer at treatable stages.


Speaking about the Foundation’s mission, Managing Trustee Mr. Kalpesh Shah stated, “These initiatives reflect RYA Cosmo Foundation’s commitment to ‘Healthcare with Compassion and Accessibility’, especially for the underprivileged sections of society.”
Music for a Cause Fundraising Chairman Mr. Prasan Kankaria emphasized, “Music for a Cause” is the spirit of this event. The concert featuring Anuv Jain, whose soulful music resonates deeply with today’s youth, is expected to draw a large and diverse audience.


President Mr. Satish Munoth of RYA Cosmo Foundation added, “This concert is more than an evening of music—it is a collective step towards saving lives through early diagnosis and quality healthcare. We are grateful to our donors, Hivefy Events, and all supporters for standing with us in this noble cause.”
The event has been made possible through the dedicated efforts of the entire organizing team, including Manish Ranka, Sanjay Gundecha, Ajay Nahar, Chiragh Chowatia, Mahesh Taleda, Anil Kothari, Abhay Lodha, along with trustees and committee members.


RYA Cosmo Foundation invites citizens, corporates, donors, and music lovers to participate and contribute towards strengthening these life-saving healthcare initiatives.

Kauvery Hospital Launches One-Tap ‘SOS’ Feature on Kauvery KARE App to Deliver Faster Emergency Care


Chennai , 22nd December 2025: Kauvery Hospital today announced the launch of its one-tap ‘SOS’ emergency feature on the Kauvery KARE app, designed to simplify and accelerate access to emergency medical care. The feature enables users to receive immediate medical support with just a single tap, and without the need to remember emergency numbers or explain their location during critical moments.
In emergency situations, panic, confusion, or unfamiliar surroundings often make it difficult for patients or bystanders to communicate essential details to emergency services. Kauvery Hospital’s SOS feature addresses this challenge by automatically capturing the user’s location through GPS, allowing the nearest ambulance to be dispatched instantly to the exact location.
At the same time, the SOS feature enables the user or bystander to connect with a doctor from Kauvery via a 24/7 video call system, ensuring real-time medical guidance and reassurance until emergency help arrives. This seamless integration of ambulance services and live medical consultation helps bridge the crucial gap between the onset of an emergency and hospital care.
Speaking on the occasion, Mr Suresh Sambandam, Founder and CEO, Kissflow said, “ True innovation turns complex problems into simple solutions. Kauvery KARE does exactly that-putting lifesaving care with just one tap away. It is inspiring to see a Tamil Nadu leader using digital innovation to solve real world needs and create a massive impact.”


Speaking at the launch, Dr Aravindan Selvaraj, Co-Founder and Executive Director, Kauvery Group of Hospitals, said, “Today, mobile apps have become a natural part of how people manage their daily lives from mobility to basic essentials that reach them within minutes. When convenience and speed are already expected in these areas, healthcare cannot remain an exception. During medical emergencies, every second matters. During such moments it is natural for patient or their attenders to be worried and in times of panic they will be unable to reach out for help or explain their situation which can lead to delays. Our goal is to remove complexity from emergency care. With the Kauvery KARE SOS feature, help is just one tap away.”
Beyond emergency support, the Kauvery KARE app serves as a comprehensive digital healthcare platform. Individuals can book appointments across any Kauvery Hospital unit, opt for video or in-person consultations, access health reports digitally, and manage medical records for multiple family members on a single app. The app is available on iOS and Android.
The launch of Kauvery KARE reflects Kauvery Hospital’s commitment to using technology to enhance accessibility, responsiveness, and continuity of care. By combining emergency response with everyday healthcare services, the app aims to provide patients with a dependable, all-in-one digital health solution—available anytime, anywhere.

Buddhi Clinic Hosts Landmark “Neurofrontiers 2025”

Buddhi Clinic Hosts Landmark “Neurofrontiers 2025” International Neuropsychiatry Colloquium

INA–GNG Partnership Brings 25 Global Experts to Chennai to Shape the Future of Brain–Mind Care

CHENNAI, December 13, 2025 – Buddhi Clinic, which has firmly established Chennai as a global hub for neuropsychiatry innovation through its pioneering interventional and integrative neuropsychiatry and advanced neurorehabilitation paradigms, is hosting Neurofrontiers 2025: The INA–GNG Colloquium.

This landmark gathering brings together 25 internationally acclaimed experts from Johns Hopkins University & Kennedy Krieger Institute (USA), Brown University (USA), University of Melbourne (Australia), Imperial College London (UK), and other world-leading institutions. Their collective mission: to redefine clinical paradigms for complex neurological and neuropsychiatric conditions.

The International Neuropsychiatric Association (INA) and the Global Neuropsychiatry Group (GNG) have partnered with Buddhi Clinic for this high-impact colloquium, recognizing its alignment with the global movement toward advanced, interventional neuropsychiatry.

This collaboration is further strengthened by the leadership roles of Buddhi Clinic: Dr. Ennapadam S. Krishnamoorthy, Founder, served an extended term as President of the INA during the Covid-19 pandemic, and Mr. Vivek Misra, Director–Neurotechnology at Buddhi Clinic, now serves on the INA Executive Committee.

Buddhi Dialogue: The Intellectual Summit of Day Two

The highlight of the second day is the Buddhi Dialogue on New Frontiers in Neuropsychiatry, featuring three globally respected clinician-scientists:

Prof. Jay A. Salpekar (Johns Hopkins University & Kennedy Krieger Institute) – Childhood Epilepsy

Prof. W. Curt LaFrance Jr. (Brown University) – Functional Neurological Disorders

Prof. David Coghill (University of Melbourne) – Attention-Deficit/Hyperactivity Disorder

Moderated by Dr. Ennapadam S. Krishnamoorthy, this intimate session represents the intellectual pinnacle of the two-day program.

“This colloquium represents the materialization of our vision to position India at the vanguard of global neuropsychiatry,” said Dr. Krishnamoorthy. “We are not simply facilitating knowledge transfer—we are actively shaping the future of how complex brain disorders are understood and treated.”
A Scientific Program That Spans the Entire Brain–Mind Spectrum

Curated by Dr. Jasvinder Singh (Founder, GNG) and Mr. Vivek Misra, with scientific guidance from Prof. Valsamma Eapen (University of New South Wales; President, INA), the program covers major frontiers in contemporary neuropsychiatry:

Neurodevelopmental disorders, Autism Spectrum Disorders

Attention-deficit and behavioural disorders

Functional neurological disorders

Traumatic brain injury and metabolic neurology

Therapeutic neuromodulation and psychedelic therapies

Deep brain stimulation and brain–computer interfaces

Artificial intelligence in neuropsychiatric diagnostics and care

Hands-On Workshops: Bridging Research and Real-World Practice

On December 14, Neurofrontiers 2025 features two specialized workshops:

Integrated Functional Electrical Stimulation – Ms. Durga D. Gawade

Non-Invasive Brain Stimulation – Mr. Vivek Misra, Head of Neuromodulation, Buddhi Clinic

These workshops translate cutting-edge research into immediate clinical application, enabling practitioners to adopt state-of-the-art protocols.

Distinguished Global Faculty

The colloquium features prominent voices from leading neuropsychiatry centers, including:

Prof. Shoumitro Deb – Imperial College London

Prof. Helen Cross – Great Ormond Street Hospital

Prof. Maria Oto – University of Edinburgh

Prof. Valsamma Eapen – University of New South Wales

Prof. Urvakhsh Mehta – NIMHANS

Their presence underscores Chennai’s emergence as a world-stage venue for neuropsychiatric thought leadership.

A Hybrid Platform Connecting Continents

Proceedings at Buddhi Clinic, Teynampet, are delivered in a hybrid format, enabling global participation. Institutions such as Kasturba Medical College (KMC) Manipal are hosting interactive classrooms where postgraduate trainees and faculty engage live with the colloquium—democratizing access to elite scientific discourse.

About Buddhi Clinic

Founded in 2009, Buddhi Clinic is internationally recognized for its leadership in interventional and integrative neuropsychiatry.

With over 15,000 patients treated, the clinic offers a unique synthesis of:

18+ therapeutic modalities

Advanced neurotechnology (non-invasive brain stimulation, precision neuropsychiatric assessments)

Multidisciplinary clinical expertise

Ancient healing wisdom and holistic care

With centers in Chennai, Coimbatore, and Indore, Buddhi Clinic is redefining personalized care for complex disorders of brain and mind.

India’s First Arthroscopic Rotator Cuff Repair with Patch Augmentation using ArthroFlex® at Chennai Upper Limb Unit

Chennai, India 12th Dec 25:

 In a remarkable milestone for Indian orthopedic surgery, Dr. Ram Chidambaram, one of India’s foremost shoulder specialists, successfully performed the country’s first arthroscopic rotator cuff repair using ArthroFlex®–HDA, at Chennai Upper Limb Unit, Chennai. This pioneering procedure marks a significant leap forward in restoring shoulder function and improving quality of life for patients suffering from complex, massive rotator cuff tears.

Speaking on the occasion, Dr. Ram Chidambaram said: “This surgery opens new possibilities for patients who were previously considered untreatable with conventional methods. ArthroFlex–HDA provides an ideal graft for restoring shoulder biomechanics, giving patients a pain-free, functional shoulder and a renewed quality of life.”

Rotator Cuff Injuries Rotator cuff tears are commonly encountered following an injury or fall. The muscles making up the rotator cuff (crucial for lifting and shoulder rotation) often wear down with age and repetitive use, increasing their propensity to tear. Patients present with significant pain, restricted range of motion and hampered ability to perform activities of daily living. Small tears can be treated conservatively, but big tears often require surgical intervention in the form of arthroscopic repair (‘keyhole surgery’). Classically, this involves reattachment of the torn tendon to the footprint of the humeral head using suture anchors. The majority of patients respond well to this procedure, but a few experience poor functional outcomes due to degenerative tissue and retears.

The rotator cuff is essentially supported by a ‘Human allograft patch’ of tissue that holds the repair together, enabling faster post-operative mobilization and reducing risk of retear. Patients also experience tremendous pain relief and better functional outcomes. Human allograft patches advanced and superior, providing increased strength, elasticity and biocompatibility. The graft preserves native cellular architecture, allowing for long-term integration into host tissue.

 Chennai Upper Limb Unit is a dedicated specialist centre in Alwarpet that exclusively caters to patients with problems affecting the shoulder, elbow, wrist and hand. Dr Ram Chidambaram, founding director of the Chennai Upper Limb Unit, is a senior consultant shoulder & upper limb surgeon with over 30 years of experience in India and the UK. His expertise is in sports medicine and treating upper limb ailments and is now regarded as one of the best shoulder and upper limb surgeons in Asia

ArthroFlex®–HDA by Avana

 ArthroFlex®–HDA has been made available in India through the work of Avana Medical Devices Pvt Ltd. The company, founded in 2009 and headquartered in Chennai.  Avana is proud to have supported this landmark case by ensuring timely and compliant access to the human dermal allograft, said Mr. P Sundararajan, Managing Director at Avana Medical Devices Pvt Ltd. “Our goal is to bridge the gap between international innovation and Indian clinical needs, so patients here can benefit from world-class solutions without delay. We are always proud to introduce new technologies in India to enable surgeons to treat their patients better.”